RITPBC: B-cell depleting therapy (rituximab) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial

INTRODUCTION: Primary biliary cirrhosis (PBC) is an autoimmune liver disease with approximately 50% of patients experiencing fatigue. This can be a particularly debilitating symptom, affecting quality of life and resulting in social isolation. Fatigue is highlighted by patients as a priority for res...

Descripción completa

Detalles Bibliográficos
Autores principales: Jopson, Laura, Newton, Julia L, Palmer, Jeremy, Floudas, Achilleas, Isaacs, John, Qian, Jessica, Wilkinson, Jennifer, Trenell, Mike, Blamire, Andrew, Howel, Denise, Jones, David E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Gastroenterology and Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550715/
https://www.ncbi.nlm.nih.gov/pubmed/26297361
http://dx.doi.org/10.1136/bmjopen-2015-007985

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550715/
https://www.ncbi.nlm.nih.gov/pubmed/26297361
http://dx.doi.org/10.1136/bmjopen-2015-007985

Ejemplares similares